ID   NOD2_HYLLA              Reviewed;        1040 AA.
AC   Q53B88;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   07-APR-2021, entry version 73.
DE   RecName: Full=Nucleotide-binding oligomerization domain-containing protein 2;
DE   AltName: Full=Caspase recruitment domain-containing protein 15;
GN   Name=NOD2; Synonyms=CARD15;
OS   Hylobates lar (Common gibbon) (White-handed gibbon).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hylobatidae;
OC   Hylobates.
OX   NCBI_TaxID=9580;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   King K., Sheikh M., Cuthbert A.P., Fisher S.A., Mirza M.M., Sanderson J.,
RA   Forbes A., Mansfield J., Roberts R.G., Mathew C.G.;
RT   "Mutation, selection and evolution of the Crohn's disease susceptibility
RT   gene, CARD15.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in gastrointestinal immunity. Upon stimulation by
CC       muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds
CC       the proximal adapter receptor-interacting RIPK2, which recruits
CC       ubiquitin ligases as XIAP, BIRC2, BIRC3, INAVA and the LUBAC complex,
CC       triggering activation of MAP kinases and activation of NF-kappa-B
CC       signaling. This in turn leads to the transcriptional activation of
CC       hundreds of genes involved in immune response. Required for MDP-induced
CC       NLRP1-dependent CASP1 activation and IL1B release in macrophages.
CC       Component of an autophagy-mediated antibacterial pathway together with
CC       ATG16L1. Plays also a role in sensing single-stranded RNA (ssRNA) from
CC       viruses. Interacts with mitochondrial antiviral signaling/MAVS, leading
CC       to activation of interferon regulatory factor-3/IRF3 and expression of
CC       type I interferon. {ECO:0000250|UniProtKB:Q9HC29}.
CC   -!- SUBUNIT: Component of a signaling complex consisting of ARHGEF2, NOD2
CC       and RIPK2. Interacts (via CARD domain) with RIPK2 (via CARD domain).
CC       Interacts with ATG16L1. Interacts (via NACHT domain) with CARD9.
CC       Interacts with ANKRD17 (via N-terminus). Interacts with HSPA1A; the
CC       interaction enhances NOD2 stability. Interacts (via both CARD domains)
CC       with HSP90; the interaction enhances NOD2 stability. Interacts (via
CC       CARD domain) with SOCS3; the interaction promotes NOD2 degradation.
CC       Interacts (via CARD domain) with ERBBI2P; the interaction inhibits
CC       activation of NOD2. Interacts (via CARD domain) with CASP1; this
CC       interaction leads to IL1B processing. Also interacts with CASP4.
CC       Interacts with NLRP1; this interaction is enhanced in the presence of
CC       muramyl dipeptide (MDP) and leads to increased IL1B release. Interacts
CC       with MAPKBP1; the interaction is enhanced in the presence of muramyl
CC       dipeptide (MDP). Interacts with INAVA; the interaction takes place upon
CC       PRR stimulation. Interacts with ANKHD1, C10ORF67, CHMP5, DOCK7, ENTR1,
CC       KRT15, LDOC1, PPP1R12C, PPP2R3B, TRIM41 and VIM (By similarity).
CC       {ECO:0000250|UniProtKB:Q9HC29}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9HC29}.
CC       Membrane {ECO:0000250|UniProtKB:Q9HC29}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:Q9HC29}.
CC   -!- DOMAIN: The ATG16L1-binding motif mediates interaction with ATG16L1.
CC       {ECO:0000250}.
CC   -!- DOMAIN: Intramolecular interactions between the N-terminal moiety and
CC       the leucine-rich repeats (LRR) may be important for autoinhibition in
CC       the absence of activating signal. In the absence of LRRs, the protein
CC       becomes a constitutive activator of CASP1 cleavage and proIL1B
CC       processing. {ECO:0000250|UniProtKB:Q9HC29}.
CC   -!- PTM: Polyubiquitinated following MDP stimulation, leading to
CC       proteasome-mediated degradation. {ECO:0000250|UniProtKB:Q9HC29}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY594161; AAS89990.1; -; Genomic_DNA.
DR   EMBL; AY594150; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594151; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594152; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594153; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594154; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594155; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594156; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594157; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594158; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594159; AAS89990.1; JOINED; Genomic_DNA.
DR   EMBL; AY594160; AAS89990.1; JOINED; Genomic_DNA.
DR   SMR; Q53B88; -.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0031982; C:vesicle; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0050700; F:CARD domain binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0032500; F:muramyl dipeptide binding; ISS:UniProtKB.
DR   GO; GO:0042834; F:peptidoglycan binding; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0071225; P:cellular response to muramyl dipeptide; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0016045; P:detection of bacterium; ISS:UniProtKB.
DR   GO; GO:0032498; P:detection of muramyl dipeptide; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0002720; P:positive regulation of cytokine production involved in immune response; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   GO; GO:0032495; P:response to muramyl dipeptide; ISS:UniProtKB.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR041267; NLRP_HD2.
DR   InterPro; IPR041075; NOD2_WH.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00619; CARD; 2.
DR   Pfam; PF13516; LRR_6; 3.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF17776; NLRC4_HD2; 1.
DR   Pfam; PF17779; NOD2_WH; 1.
DR   SUPFAM; SSF47986; SSF47986; 2.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50209; CARD; 2.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell membrane; Cytoplasm; Immunity; Innate immunity;
KW   Leucine-rich repeat; Membrane; Nucleotide-binding; Repeat; Ubl conjugation.
FT   CHAIN           1..1040
FT                   /note="Nucleotide-binding oligomerization domain-containing
FT                   protein 2"
FT                   /id="PRO_0000144090"
FT   DOMAIN          26..122
FT                   /note="CARD 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   DOMAIN          126..218
FT                   /note="CARD 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   DOMAIN          293..618
FT                   /note="NACHT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT   REPEAT          791..812
FT                   /note="LRR 1"
FT   REPEAT          816..839
FT                   /note="LRR 2"
FT   REPEAT          844..865
FT                   /note="LRR 3"
FT   REPEAT          872..884
FT                   /note="LRR 4"
FT   REPEAT          900..920
FT                   /note="LRR 5"
FT   REPEAT          928..949
FT                   /note="LRR 6"
FT   REPEAT          956..976
FT                   /note="LRR 7"
FT   REPEAT          984..1005
FT                   /note="LRR 8"
FT   REPEAT          1012..1032
FT                   /note="LRR 9"
FT   NP_BIND         299..306
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT   REGION          241..274
FT                   /note="Required for CARD9 binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HC29"
FT   MOTIF           63..77
FT                   /note="ATG16L1-binding motif"
SQ   SEQUENCE   1040 AA;  115262 MW;  2BE59A6C96AAC0D1 CRC64;
     MGEEGGSVSH DEEERASVLL GQYLGCEMCS QEAFQAQRSQ LVELLVSGSL EGFESVLDWL
     LSWEVLSWED YEGFHLLGQP LSHLARRLLD TVWNKGTWAC QKLIAAAQEA QADSQSPKLH
     GCWDPHSLHP ARDLQSHRPA IVRRLHSHVE GVLDLAWERG FVSQYECDEI RLPIFTPSQR
     ARRLLDLATV KANGLAAFLL QHVQELPVPL ALPLEAATCR KYMAKLRTTV SAQSRFLSTY
     DGAETLCLED IYTENVLEVW ADVGTAGPPP KSPATLGLEE LFSTPGHLND DADTVLVVGE
     AGSGKSTLLQ RLHLLWAAGR DFQEFLFVFP FSCRQLQCMA KPLSVRTLLF EHCCWPDVGQ
     EDIFQLLLDH PDRVLLTFDG FDEFKFRFTD RERHCSPTDP TSVQTLLFNL LQGNLLKNAR
     KVVTSRPAAV SAFLRKYIRT EFNLKGFSEQ GIELYLRKRH REPGVADRLI RLLQATSALH
     GLCHLPVFSW MVSKCHQELL LQEGGSPKTT TDMYLLILQH FLLHAIPPDS ASQGLGPSLL
     RGRLPTLLHL GRLALWGLGM CCYVFSAQQL QAAQVSPDDI SLGFLVRAKG VVPGSTAPLE
     FLHITFQCFF AAFYLALSAD VPPALLRHLF NCGRPGNSPV ARLLPTLCIQ GSEGKDSSVA
     ALLQKAEPHN LQITAAFLAG LLSREHWGLL AECQTSEKAL LRRQACARWC LARSLRKHFH
     SIPPAAPGEA KSMHAMPGFI WLIRSLYEMQ EERLARKAAR GLNVGHLKLT FCSVGPAECA
     ALAFVLQHLR RPVALQLDYN SVGDIGVEQL LPCLGVCKAL YLRDNNISDR GICKLIECAL
     HCEQLQKLVL FNNKLTDGCA HSMAKLLACR QNFLALRLGN NHITPAGAQV LAEGLRGNTS
     LQFLGFWGNR VGDEGAQALA EALGDHQSLR WLSLVGNNIG SVGAQALALM LAKNVMLEEL
     CLEENHIQDE GVCSLAEGLK KNSSLKILKL SNNCITYLGA KALLQALERN DTILEVWLRG
     NIFSLEEVDK LGCRDIRLLL
//
